Market Overview

UPDATE: Piper Jaffray Upgrades Celgene Corporation to Overweight on Reduced Revlimid Reliance

Share:

Piper Jaffray upgraded Celgene Corporation (NASDAQ: CELG) from Neutral to Overweight and raised the price target from $86.00 to $111.00.

Piper Jaffray noted, "We are upgrading CELG to Overweight from Neutral following positive top-line data from the Apremilast Phase III psoriasis studies and new 2017 guidance that supports a 25% annual EPS growth. We expect the streak of successful clinical studies and milestones, including Apremilast (psoriatic arthritis, psoriasis), Abraxane (lung cancer approval, melanoma, pancreatic), and pomalidomide (myeloma), to translate to meaningful top-line growth, lowering CELG's reliance on Revlimid performance."

Celgene Corporation closed at $85.73 on Monday.

Latest Ratings for CELG

DateFirmActionFromTo
Feb 2019Cowen & Co.Initiates Coverage OnMarket Perform
Feb 2019JefferiesDowngradesBuyHold
Jan 2019BairdUpgradesNeutralOutperform

View More Analyst Ratings for CELG
View the Latest Analyst Ratings

Posted-In: Piper JaffrayAnalyst Color Upgrades Pre-Market Outlook Analyst Ratings

 

Related Articles (CELG)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
BIIBCantor FitzgeraldDowngrades0.0
WEXSunTrust Robinson HumphreyMaintains215.0
GISCredit SuisseMaintains52.0
OWells FargoMaintains78.0
HASWells FargoMaintains82.0
View the Latest Analytics Ratings
Don't Miss Out!
Join Our Newsletter
Subscribe to:
Trader Essentials
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You
for registering for Benzinga’s newsletters and alerts.
• The Daily Analysts Ratings email will be received daily between 7am and 10am.
• The Market in 5 Minutes email will be received daily between 7am and 8am.
• The Fintech Focus email will be received every Friday between 2pm and 5pm.

UPDATE: Morgan Stanley Downgrades Rockwell Automation to Underweight on Lack of EPS Upside in 2013

UPDATE: Sterne Agee Upgrades FMC Technologies to Buy on 2013 Margin Inflection